Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview

10592studies shown

Showing 10,213-10,224 of 10,592

Drug study icon

CompletedNCT00518973

study of Quetiapine in Eating disorders

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Eating disordersDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: University of California, San Diego
Condition: Eating disorders

Device study icon

CompletedNCT00409370

study of Safety Nets In Hospitalized Patients

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDeviceOver 18 Years

Countries: United States
Sponsor: Griffin Hospital
Condition: Schizophrenia

Drug study icon

CompletedNCT00352469

study of Seroquel SR for Alcohol Dependence and Comorbid Anxiety

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Anxiety, PTSD, ...DrugFrom 19 Years to 65 Years

Countries: United States
Sponsor: Creighton University
Condition: Anxiety, PTSD, ...

Behavioral study icon

CompletedNCT00261235

study of Supported Employment Versus USES Supported Employment

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Mental healthBehavioralOver 18 Years

Countries: United States
Sponsor: VA Connecticut Healthcare System
Condition: Mental health

Behavioral study icon

CompletedNCT03302611

study of Surf and Hike Therapy for Major Depressive Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionBehavioralOver 18 Years

Countries: United States
Sponsor: United States Naval Medical Center, San Diego
Condition: Depression

Drug study icon

CompletedNCT03539887

study of the Rapid Antisuicidal Effects of Intranasal Ketamine in Comorbid Depression and Alcohol Abuse

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Depression, SuicidalityDrugFrom 21 Years to 60 Years

Countries: United States
Sponsor: The University of Texas Health Science Center, Houston
Condition: Depression, Suicidality

Behavioral study icon

CompletedNCT02421237

study of Treatment for Internalized Stigma in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaBehavioralFrom 21 Years to 65 Years

Countries: United States
Sponsor: John Jay College of Criminal Justice, City University of New York
Condition: Schizophrenia

Behavioral study icon

CompletedNCT06042400

study of Written Exposure for Metastatic Cancer Patients (EASE)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AnxietyBehavioralOver 18 Years

Countries: United States
Sponsor: University of Colorado, Boulder
Condition: Anxiety

Behavioral study icon

CompletedNCT01093599

study on the Effectiveness of Mindfulness Training for Smokers

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralOver 18 Years

Countries: United States
Sponsor: University of Wisconsin, Madison
Condition: Addiction

Drug study icon

CompletedNCT03872596

study to Assess the Bioavailability of Quetiapine Versus Seroquel® in Subjects With Schizophrenia or Bipolarity

This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.

In United States

Bipolarity, SchizophreniaDrugFrom 18 Years to 45 Years

Countries: United States
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Bipolarity, Schizophrenia

Drug study icon

CompletedNCT03292848

Study to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders

This study is completed in the United States. It focuses on ADHD.

In United States

ADHD, BipolarityDrugFrom 6 Years to 12 Years

Countries: United States
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: ADHD, Bipolarity

Drug study icon

CompletedNCT07486895

study to Demonstrate the Equivalence of Two Different Strengths of Oral Centanafadine Capsules in Healthy Subjects

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: ADHD

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.